The biochemical features of phenyl- ClPhe + Phe in adult rats to produce a lowered hepatic phenylalanine hydroxylase activity and an elevated blood phenylalanine level without associated tyrosinemia. When rats were treated with this regimen before they were weaned, during the critical first 21 days of life, they showed, during the treatment period, biochemical (3) and electrophysiological (4) abnormalities typical of PKU. Their behavioral abnormalities persisted throughout adult life (5). The present work is directed toward extending the previous investigations of model PKU in rats, especially in the area of permanent learning deficits which result from the early treatment with ClPhe + Phe. Other recent investigations using ClPhe + Phe as a method of PKU production include the behavioral studies of Vorhees et al. (6) and Butcher et al. (7, 8) and the biochemical studies of Edwards and Blau (9, 10).
Phenylketonuria (PKU) is an inherited disorder of phenylalanine metabolism for which an adequate animal model has been sought. The well-defined biochemical changes resulting from this single gene defect cause the brain to develop abnormally, resulting in severe mental retardation, hyperactivity, increased seizure susceptibility, and muscular hypertonicity (1) .
The biochemical features of PKU have been most closely approximated by the use of p-chloro-Diphenylalanine plus i-phenylalanine (ClPhe + Phe). Lipton et al. (2) first used ClPhe + Phe in adult rats to produce a lowered hepatic phenylalanine hydroxylase activity and an elevated blood phenylalanine level without associated tyrosinemia. When rats were treated with this regimen before they were weaned, during the critical first 21 days of life, they showed, during the treatment period, biochemical (3) and electrophysiological (4) abnormalities typical of PKU. Their behavioral abnormalities persisted throughout adult life (5) . The present work is directed toward extending the previous investigations of model PKU in rats, especially in the area of permanent learning deficits which result from the early treatment with ClPhe + Phe. Other recent investigations using ClPhe + Phe as a method of PKU production include the behavioral studies of Vorhees et al. (6) and Butcher et al. (7, 8) and the biochemical studies of Edwards and Blau (9, 10) .
METHODS

Model phenylketonuria production
This procedure is identical to that reported previously (5) . After delivery, 12 litters were assigned to the control group given saline and 22 (11) . After the rats were decapitated, the brain was exposed and the head immersed in formalin-saline for 48 hr. The brain was then removed, weighed, and submitted for 8-or 10-step serial sections. At each step one slide was prepared with H& E, one with Heidenhain's myelin stain, and, in the 10-day-old litter, one with thionine. This procedure was slightly modified for the preparation at 1 year of age of 3 females given saline and 3 females given ClPhe + Phe (12) .
Statistics
Probability figures refer to the Student's t-test. Where more than one comparison of means is possible the conservative F.S.D. procedure is used (13) . In this procedure, the significance level is divided by the number of comparisons of interest. For example, if there are two comparisons of interest, e.g., saline compared with ClPhe + Phe and saline compared with undernourished, the significance level becomes the tvalue which gives a probability of 5% divided by two comparisons; in other words, a probability of < 0.025 is now required. RESULTS Body Weights (Table 1) . At the end of the treatment period, the group given ClPhe + Phe was significantly lower in weight than the controls given saline, about two-thirds control weight. By day 39 all the animals given ClPhe + Phe had attained the weight of the controls given saline and remained so throughout these experiments. The undernourished animals weighed about the same as the animals given ClPhe + Phe at the end of the treatment period. However, the male undernourished animals continued to be significantly lower in weight at 39 days (P < 0.01) and 18 weeks (P < 0.0025). The undernourished females were also lower in weight at 39 days and at 18 weeks (P < 0.1). The F.S.D. level of significance here is P < 0.025.
Eye Opening. Controls given saline opened their eyes at 16.8 days of age on the average, significantly before the group given ClPhe + Phe, which opened their eyes at 18.0 days (P < 0.001). Undernourished controls opened their eyes at 17.0 days, not significantly different from controls given saline.
F.S.D. level of significance is again P < 0.025. Activity Wheel (Fig. 1) . The ClPhe + Phe-treated subjects, both males and females. were more active than their controls given saline (P < 0.025 for males, P < 0.01 for females). The repeated measure of the activity of the males confirmed the initial results (P < 0.025). The activity of 17 undernourished females tested at 29 weeks of age was not significantly different from that of 7 well-nourished females raised simultaneously and tested at the same age.
Active Avoidance in a Two-Way Shuttlebox. There was no difference between saline-and ClPhe + Phe-treated animals in simple two-way shuttlebox active avoidance.
Active Avoidance with a Right-Left Position Choice (Fig. 2) .
There was no significant difference between saline-treated and The CiPhe + Phe-treated subject required 30%O more trials during the actual testing to reach criterion, and retained the position learning less than half as well as the saline-treated rats when retested 2 weeks later. The ClPhe + Phe-treated subjects were described as being less motivated to learn than the saline-treated controls during all phases of the training. (14) .
Neuropathology and Brain Weights (Fig. 3 ). Procedures were conducted by Dr. Anatole Dekaban, Section on Neurological Development, National Institute of Neurological Diseases and Stroke. The cerebellum of the 10-day-old ClPhe + Phe-treated animals was smaller than those of the saline-treated controls. Additionally, the cells in the external granular layer of the cerebellum were reduced in number. The 20-day-old experimental animals showed a slightly thinner white-matter area, but there were no focal lesions and no obvious myelin deficits. In the 39-day-old ClPhe + Phetreated animals, the cerebellum and brainstem were about 20% smaller in diameter than those of the saline-treated controls. The myelin in the ClPhe + Phe-treated animals stained considerably lighter than that of the saline-treated animals. The brain weights of the ClPhe + Phe-treated animals averaged 76% of controls on day 10 and 86% of controls on day 20.
DISCUSSION
This paper reports further observations on the enduring behavioral deficits found in rats with model PKU treated with ClPhe + Phe during the first 21 days of life. By use of a new set of litters and different methods of testing, the results reported previously (5), i.e., hyperactivity and learning deficits in adult animals, have been extended. In addition, data suggesting a delay in neural development are presented.
A control group of moderately undernourished animals was included to assess the contribution of the temporary lowering in weight during the treatment period to the total deficit of the phenylketonuric animals. The data indicate that moderate undernutrition does not delay eye opening significantly and suggests that ClPhe + Phe retards cerebral development be-Biochemistry: Andersen yond that caused by weight deficiency alone. Smart and Dobbing's undernourished animals (15) showed a significant delay in eye opening, but their experimental undernourished animals weighed only one-third that of controls. In contrast, the moderately undernourished animals in these experiments weighed two-thirds that of controls at the end of the treatment period, about the same, happily, as the group with PKU.
The data showing that all the subjects with PKU achieved the weight of the saline-treated controls by day 39, whereas, the male undernourished animals did not, suggest another difference between these groups. This difference is consistent with published reports that the decreased body weight resulting from early malnutrition is a permanent effect (16) . Finally, the activity of the undernourished animals was not different from that of normally nourished, uninjected controls, when studied with the activity wheel. Thus, it appears that the effects of the ClPhe + Phe treatment are not primarily due to the moderate decrease in body weight occurring during the treatment period.
The activity wheels were chosen instead of the open field, which was used previously (5) , to test activity for several reasons. (i) testing is done at night when the animals are more active; (ii) the activity-monitoring period is 15 hr instead of 5 min; and (iii) the activity wheels are less subject to the effects of pretesting variables such as handling, which may affect results on the open field test. In this study, both treated males and females were more active than their controls. These data agree with the clinical reports of restlessness and hyperactivity among children with PKU. Previous studies with ClPhe + Phe have found either hypoactivity (6) or no difference between experimental and control subjects (7, 8) . The Phe-treated subjects do well on two-way active avoidance, a test in which the learning task is simple and a high degree of activity is involved, suggests that differences in activity do not explain differences in performance on more complex learning tasks. Nevertheless, specific measures of starting times and running speeds would be desirable. Early hyperphenylalaninemia causes a global change in the development of the brain, and motivational differences probably also contribute to the overall learning deficit. The data in these experiments do not explain why there is a difference in the impairment profile on the results of the two active avoidance tests.
The most consistent neuropathological findings in patients with PKU have been decreased brain weight, increased gliosis, and a variable myelin deficit (20) . The disparity between the moderate neuropathological changes and the severe intellectual deficit is impressive. It is clear that we don't understand in detail how the hyperphenylalaninemia of PKU causes mental retardation. An important fact to consider is that in addition to the contribution of an enduring structural neuropathology to mental retardation, a brain that develops too slowly will leave permanent functional changes even after the brain "catches up" in appearance because the necessary physical substrate for some learning was not present at the critical period when it was required. The present data show that the brains of treated animals range from 76 to 86% of controls during the treatment period. This difference is greater than the 5% difference found previously for mature adult animals (5) who have shown complete body weight recovery, indicating that partial recovery of the deficit in brain weight occurs as the animal matures. Hole (19) , treating rat pups intraperitoneally with ClPhe alone, noted a 5.5% decrease in brain weight on day 15.
The two consistent findings on neuropathological examination of our treated rats during the development phase have been a reduction in the size of the brain compared with controls and some general defect in myelin staining. The defect is diffuse, not focal. There is an accompanying reduction in the number of cells in the external granular layer of the cerebellar cortex, an area that undergoes considerable development postnatally and is subject to effects that inhibit or retard cell division (21) . The differences in staining between the ClPhe + Phe-treated and the control animals may be a reflection of a defect similar to that found upon comparing the biochemistry of normal myelin and myelin from subjects with PKU. Such studies show a markedly lower cerebroside content of the white matter in phenylketonurics (22) .
In summary, the treatment of rat pups with ClPhe + Phe during the critical period of rapid brain growth between birth and 21 days of age results in a delay before weaning in neural development and enduring behavioral changes in activity and performance on learning tests in adult animals. Associated with these behavioral abnormalities is a lower than normal brain weight and a deficit in myelination.
We feel the use of ClPhe + Phe in rat pups before they are weaned results in reproducible and enduring changes in adult behavior which have many similarities to the behavioral disorder associated with clinical phenylketonuria.
